-
digital.ahrq.gov/sites/default/files/docs/publication/r18hs017203-gurwitz-final-report-2011.pdf
January 01, 2011 - considering expanding the 45-day requirement, as it may be too
stringent in a number of instances (e.g., liver
-
www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patientsafetyculture/asc/ascwebinar/ascwebcast0715_transcript.pdf
September 01, 2015 - We provide comprehensive
care for diseases of the digestive system and liver for adult patients, and
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/6fMLEz4CfAVoj9YBYVbm73
April 17, 2018 - Vitamin D3 is converted to its active form through enzymatic pro-
cesses in the liver and kidney.
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/JxCqP7cXvVRftQGUDJZdB-
December 01, 2014 - Behavioral Counseling Interventions to Prevent Sexually Transmitted
Infections: U.S. Preventive Services Task Force Recommendation
Statement
Michael L. LeFevre, MD, MSPH, on behalf of the U.S. Preventive Services Task Force*
Description: Update of the U.S. Preventive Services Task Force
(USPSTF) 2008 recommendation on…
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/alcohol-misuse-screening-and-behavioral-counseling-interventions-in-primary-care-2013
May 15, 2013 - misuse plays a contributing role in a wide range of health conditions, such as hypertension, gastritis, liver
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-tests-genetic_methods.pdf
July 01, 2012 - Some individuals have mild symptoms, while others experience life-threatening
complications such as liver
-
www.ahrq.gov/sites/default/files/wysiwyg/research/findings/nhqrdr/2023-nhqdr-es-rev.pdf
January 01, 2023 - expectancy), unintentional injuries (15.9%, a plurality
of which were drug overdose), heart disease (4.1%), liver
-
effectivehealthcare.ahrq.gov/health-topics/viral-infections
-
effectivehealthcare.ahrq.gov/health-topics/thalassemia
-
effectivehealthcare.ahrq.gov/health-topics/alcohol
-
effectivehealthcare.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1512.pdf
December 01, 2015 - the
U.S. and increases the risk of developing type 2 diabetes, atherosclerosis, non-alcoholic fatty liver … hyperglycemia and blocks the effects of glucagon, a
hormone produced in the pancreas that signals the liver
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-future-research-steps-framework_research.pdf
June 01, 2011 - type of outcomes or to only list the types of
outcomes (e.g., maternal outcomes and fetal outcomes, liver … Examples of outcomes include: neonatal hypoglycemia, neonatal intensive care unit (NICU)
admissions; liver … type of
outcomes or to only list the types of outcomes (e.g., maternal outcomes and fetal outcomes, liver
-
hcup-us.ahrq.gov/db/nation/nrd/Introduction_NRD_2010-2015.pdf
January 01, 2015 - Hypothyroidism:
(1) comorbidity present, (0) comorbidity not
present
CM_LIVER AHRQ comorbidity measure - Liver … 37,987 17.16 17.53 2.2
15: Cancer of rectum and
anus 12,496 21.26 21.68 2.0
16: Cancer of liver … abscess 8,092 27.39 28.28 3.2
149: Biliary tract disease 107,986 14.87 15.38 3.4
151: Other liver
-
hcup-us.ahrq.gov/reports/annualreport/HAR_2005.pdf
January 01, 2005 - cardiomyopathy
535.3 Alcoholic gastritis
535.31 Alcoholic gastritis, with hemorrhage
571.0 Alcoholic fatty liver … 571.1 Acute alcoholic hepatitis
571.2 Alcoholic cirrhosis of liver
571.3 Alcoholic liver damage,
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/medication-therapy-management-1_research.pdf
July 01, 2012 - Demographics, Allergies, Medical History, Chemistries, Complete Blood Count, Vitals,
Diabetes, Drug Levels, Liver … Platelets (/mcl) Date Lab Drawn: / /
BUN (mg/dL) HbA1C (%)
Lipid Panel
Liver
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/colon-cancer-gene-profiling_technical-brief.pdf
December 01, 2012 - For example, recurrence was sometimes considered only as cancer metastatic to liver or lung
25 … The gene expression profile represents the molecular nature of liver
metastasis in colorectal cancer
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/version-2-risk-of-reinfection-from-SARSCoV2_0.pdf
December 31, 2022 - Clinical
Trials.gov
Anticipated
Primary
Completion
Date
Humoral Immunity
Against SARS-CoV-2 in
Liver … After COVID-
19 in Comparison With
Immunocompetent
Patients
NCT04410471
Case-control
Spain
Liver
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/insulin-blood-sugar_research.pdf
August 01, 2015 - secretion from the pancreatic beta cells; resistance to insulin
action at the level of skeletal muscle, liver … secretion from the pancreatic beta cells; resistance to insulin
action at the level of skeletal muscle, liver
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/LPaUxRbrTshfsYVVTzenEQ
April 26, 2022 - factors include male sex, diabetes, history of gastroin-
testinal issues (such as peptic ulcer disease), liver
-
hcup-us.ahrq.gov/reports/natstats/his96/table2.pdf
February 11, 2011 - $13,924 $6,381 $10,307 $16,387 6.7 2.2 39.1 60.6
pancreas (ERCP) [82.]
9.15 Biopsy of liver